You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

talazoparib

Showing 1 - 25 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial (ADT, Enzalutamide, Talazoparib)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
May 15, 2023

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Active, not recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial (ART6043, Olaparib, Talazoparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Jun 1, 2023

Metastatic Castration-Resistant Prostate Cancer Trial (Talazoparib)

Available
  • Metastatic Castration-Resistant Prostate Cancer
  • Talazoparib
  • (no location specified)
Dec 6, 2022

Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

Recruiting
  • Breast Cancer
  • Talazoparib
  • Sacituzumab Govitecan
  • Boston, Massachusetts
  • +1 more
Jan 6, 2023

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Baltimore, Buffalo (Gemtuzumab Ozogamicin,

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin
  • +4 more
  • Baltimore, Maryland
  • +1 more
Dec 13, 2022

Metastatic Prostate Cancer Trial in Spain (Enzalutamide, Talazoparib)

Recruiting
  • Metastatic Prostate Cancer
  • Badalona, Spain
  • +8 more
Jan 18, 2023

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial (Pidnarulex, Talazoparib)

Not yet recruiting
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jun 15, 2022

Among Talazoparib-Treated HER2-Negative mBC With gBRCA1/2m

Completed
  • Metastatic Breast Cancer
  • Breast Neoplasms
  • Talazoparib
  • New York, New York
    Pfizer Inc.
Aug 5, 2022

Acute Myeloid Leukemia Trial in Stanford (Talazoparib, Topotecan, Gemcitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Talazoparib
  • +2 more
  • Stanford, California
    Stanford University
Jun 10, 2022

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +7 more
  • BET Bromodomain Inhibitor ZEN-3694
  • Talazoparib
  • Atlanta, Georgia
  • +2 more
Nov 3, 2022

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Pittsburgh (ZEN003694, Talazoparib)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Apr 27, 2022

Kidney Cancer, Renal Cell Carcinoma, Unresectable Renal Cell Carcinoma Trial in United States (Talazoparib, Axitinib)

Recruiting
  • Kidney Cancer
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
Jun 28, 2022

Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)

Recruiting
  • Metastatic or Unresectable Melanoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Mar 22, 2022

Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Ovarian Carcinoma Trial in Ann Arbor

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 31, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Biopsy
  • Talazoparib
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

HRD 100 Gene Expression High, Triple Negative Breast Cancer Trial in Kuala Lumpur (Talazoparib)

Recruiting
  • HRD 100 Gene Expression High
  • Triple Negative Breast Cancer
  • Talazoparib
  • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
    University Malaya Medical Centre
Mar 15, 2022

Tumors Trial in Changchun, Beijing (talazoparib)

Completed
  • Neoplasms
  • talazoparib
  • Changchun, Jilin, China
  • +1 more
Jan 12, 2022

Advanced Solid Tumor Trial in Worldwide (RP-3500, Talazoparib, Gemcitabine Injection [Gemzar])

Recruiting
  • Advanced Solid Tumor
  • Chicago, Illinois
  • +12 more
Nov 18, 2022